Lung cancer: a scan that detects early and an injection that may prevent it
An oncologist discusses the evolution of lung cancer treatment, highlighting that while survival rates for advanced cases have improved, early detection remains the most critical factor. The article advocates for a dual approach focusing on both screening programs and emerging vaccine research.
Why it matters
Lung cancer is a leading cause of death, and shifting focus toward early detection and preventative vaccines could significantly reduce mortality rates globally.
For most of the last century, a diagnosis of lung cancer was often regarded as a death sentence. As an oncologist, I have witnessed dramatic changes over the past two decades, particularly in the last five years. Long-term survival in patients with advanced lung cancer, once virtually unheard of, is no longer rare. This progress reflects remarkable advances in medical science.
The article presents a medical perspective based on clinical observations without political or ideological framing.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in